Events Archive

The Scientific Journey of Lenacapavir: From basic science to clinical development to impact

Join us for the compelling story of the development of lenacapavir and the critical role of US support. Wes Sundquist, from the University of Utah, will share the story of capsid inhibitor discovery; and Linda-Gail Bekker, from the Desmond Tutu HIV Foundation, will discuss the critical role of South Africa in clinical development; all of…

Vision to Action: Unveiling the national black HIV prevention research agenda

This webinar will introduce a bold, Black-led blueprint designed to guide HIV prevention research that centers the needs, voices, and leadership of Black communities across the United States. Developed through conversations with over 1,000 Black researchers, community members, and health advocates, this agenda represents a national call to align research, funding, and policy with the…

A New Era of HIV Prevention: Accelerating access to long-acting technologies through sustainable prevention systems and financing

Convened alongside the World Health Assembly, this ministerial dialogue, co-hosted by UNAIDS, UNFPA, WHO, UNDP, the Federal Republic of Brazil, and the Kingdom of the Netherlands, will bring together Ministers of Health, global partners, pharmaceutical leaders, and civil society to: Build consensus and political momentum for a new era of HIV prevention and accelerated global…

HIV Prevention Outcomes Monitoring Webinar

Click here for the recording, notes, and related resources. Join the South to South Learning Network on 15 May 2025 for an engaging webinar on the latest thinking on HIV prevention outcomes monitoring, including the introduction of a new data-driven decision-making tool. Building on the momentum of the Prevention Outcome Monitoring Workshop held in September…

Developments in the HIV and STIs Biomedical Prevention Pipeline: An update for community educators and advocates

See here for recording and slides. This interactive e-meeting for community educators and advocates will provide an update on the latest developments in biomedical HIV and STIs prevention research and implementation, new approaches and future challenges. This will also be an opportunity to explore how these can be translated into accessible, community-informed interventions. A special…

I Am More Than HIV Prevention: Results from the HPTN 091 study with transgender women

HPTN 091, the I Am study, evaluated the impact of a multicomponent HIV prevention strategy to increase the uptake and adherence of pre-exposure prophylaxis (PrEP) among transgender women. The strategy included HIV prevention services, gender-affirming hormone therapy, and peer health navigation. This webinar will feature Dr. Tonia Poteat, Ph.D., Duke University School of Nursing, Division…

Update on Injectable Lenacapavir for PrEP

Please join AVAC for updates on the PURPOSE trials for injectable lenacapavir for PrEP. Gilead will provide an overview of the PURPOSE 1 and 2 trial results as well as insight into the status of PURPOSE 3, 4, and 5.

True Choice in HIV Prevention Involves More than Product Options: Novel strategies in service delivery

Video Recording and English Audio / Portuguese Audio / Spanish Audio / Ukrainian Audio / Slides / Resources Join The Choice Agenda and presenters from Brazil, Kenya, and South Africa to discuss novel strategies for the delivery of HIV prevention interventions. All HIV prevention products have their “Achilles Heels.” Differentiated service delivery supports reaching a…

Building a Comprehensive Approach to HIV Prevention: Strengthening Gender-Based Violence Response in PrEP Services

Slides / Recording Experiencing gender-based violence (GBV) hinders access to and effective use of HIV prevention products by those who would benefit most from them, especially adolescent girls and young women. While the introduction of new PrEP products is an exciting development for HIV prevention programs worldwide, optimizing the impact of PrEP choice requires understanding…

Launch of the PrEP Ring Early Market Access Vehicle (EMAV)

Slides / Recording This virtual event will launch the PrEP Ring Early Market Access Vehicle (EMAV), recently announced by CIFF in partnership with the Global Fund. This initiative will provide up to $2 million USD to purchase up to 150,000 dapivirine vaginal rings in countries implementing Global Fund HIV grants. More information is available in…